为进一步加强学术交流合作，营造浓厚学术氛围，推动科研灵感互鉴，激发科研创新活力，健康大数据研究院拟面向全校师生组织开展学术沙龙活动，欢迎各位老师同学踊跃报名参加，谢谢。

活动时间：2024年5月29日（周三）下午14:00-16:00

活动内容：

1、第一环节（60分钟）：学术报告与科研交流。

2、第二环节（60分钟）：介绍UNC生物统计博士项目的培养模式并与同学们交流。

邀请嘉宾：Prof. Danyu Lin (林丹瑜教授)

嘉宾简介：Danyu Lin, Ph.D., is the Dennis Gillings Distinguished Professor of Biostatistics at the University of North Carolina at Chapel Hill. Dr. Lin has published 300 papers, with 45,000 citations and an h-index of 97. The statistical methods he developed have been used in thousands of scientific studies. His publications on COVID-19 vaccines and treatments (5 in New England Journal of Medicine, 3 in JAMA, and 2 in Lancet —all as first and corresponding author) have been viewed 1 million times, cited by the Centers for Disease Control and Prevention, the Food and Drug Administration, the European Medicines Agency, and the World Health Organization, and reported by The New York Times, The Washington Post, and NBC News. Dr. Lin is an elected fellow of American Statistical Association and Institute of Mathematical Statistics, a recipient of Mortimer Spiegelman Award from American Public Health Association, and a recipient of George W. Snedecor Award from the Committee of Presidents of Statistical Societies.

报告主题：Evaluating the Effectiveness of COVID-19 Vaccines

报告摘要：Approximately 800 million COVID-19 cases and 7 million COVID-19 deaths have been reported to the World Health Organization thus far. Vaccination is a major tool to combat the COVID-19 pandemic, but its effectiveness wanes over time and tends to be lower against new SARS-CoV-2 variants. The knowledge about the waning effects of vaccination can guide boosting strategies. In a series of papers published in New England Journal of Medicine, JAMA and The Lancet, we reported several large cohort studies using COVID-19 vaccination and case surveillance data from the states of North Carolina and Nebraska, as well as electronic health records from the Cleveland Clinic Health System. We developed a novel statistical framework to evaluate the time-varying effects of the three generations of COVID-19 vaccines produced in the United States on infections with different SARS-CoV-2 variants and on severe outcomes (hospitalization and death). Our findings have been used by the World Health Organization and the U.S. Centers for Disease Control and Prevention and Food and Drug Administration and reported by The New York Times, The Washington Post and NBC News.

报名方式：如您有意参加，请于2024年5月27日（周一）17:00前扫描下方问卷星填写报名信息，提交报名信息后将显示会议群二维码，请及时扫码入群，会议地点将在群内通知，谢谢！